** Shares of medical devices maker VIVE.O jump 11.8% to
$5.37
** U.S. FDA approves expasion of manufacturing capacity for
consumable component used with co's Cryogen-cooled Monopolar
Radiofrequency technology (https://bit.ly/39ArwzC)
** Expansion will help in reductions in treatment component
manufacturing costs, and strengthen supply chain - VIVE
** Stock down ~58% YTD
(Reporting by Mrinalika Roy in Bengaluru)
((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))